{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28117389", "DateCompleted": {"Year": "2018", "Month": "10", "Day": "22"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "01", "Day": "24"}], "Language": ["eng"], "ELocationID": ["41406", "10.1038/srep41406"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "7", "PubDate": {"Year": "2017", "Month": "Jan", "Day": "24"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "The identification and molecular mechanism of anti-stroke traditional Chinese medicinal compounds.", "Pagination": {"StartPage": "41406", "MedlinePgn": "41406"}, "Abstract": {"AbstractText": ["Stroke is a worldwide epidemic disease with high morbidity and mortality. The continuously exploration of anti-stroke medicines and molecular mechanism has a long way to go. In this study, in order to screen candidate anti-stroke compounds, more than 60000 compounds from traditional Chinese medicine (TCM) database were computationally analyzed then docked to the 15 known anti-stroke targets. 192 anti-stroke plants for clinical therapy and 51 current anti-stroke drugs were used to validate docking results. Totally 2355 candidate anti-stroke compounds were obtained. Among these compounds, 19 compounds are structurally identical with 16 existing drugs in which part of them have been used for anti-stroke treatment. Furthermore, these candidate compounds were significantly enriched in anti-stroke plants. Based on the above results, the compound-target-plant network was constructed. The network reveals the potential molecular mechanism of anti-stroke for these compounds. Most of candidate compounds and anti-stroke plants are tended to interact with target NOS3, PSD-95 and PDE5A. Finally, using ADMET filter, we identified 35 anti-stroke compounds with favorable properties. The 35 candidate anti-stroke compounds offer an opportunity to develop new anti-stroke drugs and will improve the research on molecular mechanism of anti-stroke."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650223, China."}, {"Identifier": [], "Affiliation": "Kunming College of Life Science, University of Chinese Academy of Sciences, Kunming, 650204, China."}], "LastName": "Liu", "ForeName": "Jia-Qian", "Initials": "JQ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650223, China."}, {"Identifier": [], "Affiliation": "Kunming College of Life Science, University of Chinese Academy of Sciences, Kunming, 650204, China."}], "LastName": "Dai", "ForeName": "Shao-Xing", "Initials": "SX"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650223, China."}, {"Identifier": [], "Affiliation": "Kunming College of Life Science, University of Chinese Academy of Sciences, Kunming, 650204, China."}], "LastName": "Zheng", "ForeName": "Jun-Juan", "Initials": "JJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650223, China."}], "LastName": "Guo", "ForeName": "Yi-Cheng", "Initials": "YC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650223, China."}, {"Identifier": [], "Affiliation": "Institute of Health Sciences, Anhui University, Hefei, 230601, China."}], "LastName": "Li", "ForeName": "Wen-Xing", "Initials": "WX"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650223, China."}, {"Identifier": [], "Affiliation": "Kunming College of Life Science, University of Chinese Academy of Sciences, Kunming, 650204, China."}], "LastName": "Li", "ForeName": "Gong-Hua", "Initials": "GH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650223, China."}, {"Identifier": [], "Affiliation": "Kunming College of Life Science, University of Chinese Academy of Sciences, Kunming, 650204, China."}, {"Identifier": [], "Affiliation": "Chinese University of Hong Kong Joint Research Center for Bio-resources and Human Disease Mechanisms, Kunming, 650223, China."}, {"Identifier": [], "Affiliation": "KIZ-SU Joint Laboratory of Animal Models and Drug Development, College of Pharmaceutical Sciences, Soochow University, Kunming, 650223, China."}, {"Identifier": [], "Affiliation": "Kunming Biological Diversity Regional Center of Instruments, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650223, China."}], "LastName": "Huang", "ForeName": "Jing-Fei", "Initials": "JF"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Medicine, Chinese Traditional"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Stroke"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Neurological disorders: Public health challenges. World Health Organization 151\u2013163 (2006)."}, {"Citation": "Sacco R. L. et al.. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke; a journal of cerebral circulation 44, 2064\u20132089, doi: 10.1161/STR.0b013e318296aeca (2013).", "ArticleIdList": ["10.1161/STR.0b013e318296aeca", "23652265"]}, {"Citation": "Green A. R. Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly. British journal of pharmacology 153 Suppl 1, S325\u2013338, doi: 10.1038/sj.bjp.0707594 (2008).", "ArticleIdList": ["10.1038/sj.bjp.0707594", "PMC2268079", "18059324"]}, {"Citation": "Moustafa R. R. & Baron J. C. Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery. British journal of pharmacology 153 Suppl 1, S44\u201354, doi: 10.1038/sj.bjp.0707530 (2008).", "ArticleIdList": ["10.1038/sj.bjp.0707530", "PMC2268043", "18037922"]}, {"Citation": "Akins P. T., Liu P. K. & Hsu C. Y. Immediate early gene expression in response to cerebral ischemia. Friend or foe? Stroke; a journal of cerebral circulation 27, 1682\u20131687 (1996).", "ArticleIdList": ["8784149"]}, {"Citation": "Linnik M. D., Zobrist R. H. & Hatfield M. D. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke; a journal of cerebral circulation 24, 2002\u20132008; discussion 2008\u20132009 (1993).", "ArticleIdList": ["8248983"]}, {"Citation": "Whyte E. M. et al.. An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients. Cerebrovascular diseases 26, 317\u2013321, doi: 10.1159/000149580 (2008).", "ArticleIdList": ["10.1159/000149580", "PMC2914451", "18667813"]}, {"Citation": "Pohanka M. Alpha7 nicotinic acetylcholine receptor is a target in pharmacology and toxicology. International journal of molecular sciences 13, 2219\u20132238, doi: 10.3390/ijms13022219 (2012).", "ArticleIdList": ["10.3390/ijms13022219", "PMC3292018", "22408449"]}, {"Citation": "Jiang T., Gao L., Lu J. & Zhang Y. D. ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke. Current neuropharmacology 11, 209\u2013217, doi: 10.2174/1570159X11311020007 (2013).", "ArticleIdList": ["10.2174/1570159X11311020007", "PMC3637674", "23997755"]}, {"Citation": "Giossi A. et al.. Advances in antiplatelet therapy for stroke prevention: the new P2Y12 antagonists. Current drug targets 11, 380\u2013391 (2010).", "ArticleIdList": ["20210760"]}, {"Citation": "Cook D. J., Teves L. & Tymianski M. Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain. Nature 483, 213\u2013217, doi: 10.1038/nature10841 (2012).", "ArticleIdList": ["10.1038/nature10841", "22388811"]}, {"Citation": "Jones N. Stroke: Disruption of the nNOS\u2013PSD-95 complex is neuroprotective in models of cerebral ischemia. Nat Rev Neurol. 7, 61\u201361 (2011)", "ArticleIdList": ["21391317"]}, {"Citation": "Yin K. J. et al.. KLF11 mediates PPARgamma cerebrovascular protection in ischaemic stroke. Brain : a journal of neurology 136, 1274\u20131287, doi: 10.1093/brain/awt002 (2013).", "ArticleIdList": ["10.1093/brain/awt002", "PMC3613710", "23408111"]}, {"Citation": "Michalik L. et al.. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacological reviews 58, 726\u2013741, doi: 10.1124/pr.58.4.5 (2006).", "ArticleIdList": ["10.1124/pr.58.4.5", "17132851"]}, {"Citation": "Lindgren A., Lindoff C., Norrving B., Astedt B. & Johansson B. B. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients. Stroke; a journal of cerebral circulation 27, 1066\u20131071 (1996).", "ArticleIdList": ["8650716"]}, {"Citation": "Vaughan D. E. PAI-1 and atherothrombosis. Journal of thrombosis and haemostasis: JTH 3, 1879\u20131883, doi: 10.1111/j.1538-7836.2005.01420.x (2005).", "ArticleIdList": ["10.1111/j.1538-7836.2005.01420.x", "16102055"]}, {"Citation": "Giles M. F. & Rothwell P. M. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. The Lancet. Neurology 6, 1063\u20131072, doi: 10.1016/S1474-4422(07)70274-0 (2007).", "ArticleIdList": ["10.1016/S1474-4422(07)70274-0", "17993293"]}, {"Citation": "Jamieson D. G. Diagnosis of ischemic stroke. The American journal of medicine 122, S14\u201320, doi: 10.1016/j.amjmed.2009.02.006 (2009).", "ArticleIdList": ["10.1016/j.amjmed.2009.02.006", "19332239"]}, {"Citation": "Paciaroni M. & Bogousslavsky J. Primary and secondary prevention of ischemic stroke. European neurology 63, 267\u2013278, doi: 10.1159/000285183 (2010).", "ArticleIdList": ["10.1159/000285183", "20357456"]}, {"Citation": "Ginsberg M. D. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 55, 363\u2013389, doi: 10.1016/j.neuropharm.2007.12.007 (2008).", "ArticleIdList": ["10.1016/j.neuropharm.2007.12.007", "PMC2631228", "18308347"]}, {"Citation": "Sacco R. L., Chong J. Y., Prabhakaran S. & Elkind M. S. Experimental treatments for acute ischaemic stroke. Lancet 369, 331\u2013341, doi: 10.1016/S0140-6736(07)60155-X (2007).", "ArticleIdList": ["10.1016/S0140-6736(07)60155-X", "17258673"]}, {"Citation": "Chen C. Y. TCM Database@Taiwan: the world\u2019s largest traditional Chinese medicine database for drug screening in silico. PloS one 6, e15939, doi: 10.1371/journal.pone.0015939 (2011).", "ArticleIdList": ["10.1371/journal.pone.0015939", "PMC3017089", "21253603"]}, {"Citation": "Viscoli C. M. et al.. A clinical trial of estrogen-replacement therapy after ischemic stroke. The New England journal of medicine 345, 1243\u20131249, doi: 10.1056/NEJMoa010534 (2001).", "ArticleIdList": ["10.1056/NEJMoa010534", "11680444"]}, {"Citation": "Mueck A. O., Seeger H. & Buhling K. J. Use of dydrogesterone in hormone replacement therapy. Maturitas 65, S51\u2013S60, doi: 10.1016/j.maturitas.2009.09.013 (2009).", "ArticleIdList": ["10.1016/j.maturitas.2009.09.013", "19836909"]}, {"Citation": "Vigen R. et al.. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. Jama 310, 1829\u20131836, doi: 10.1001/jama.2013.280386 (2013).", "ArticleIdList": ["10.1001/jama.2013.280386", "24193080"]}, {"Citation": "Wammes-van der Heijden E. A., Rahimtoola H., Leufkens H. G., Tijssen C. C. & Egberts A. C. Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology 67, 1128\u20131134, doi: 10.1212/01.wnl.0000240128.76399.fa (2006).", "ArticleIdList": ["10.1212/01.wnl.0000240128.76399.fa", "17030745"]}, {"Citation": "Kimberly W. T. et al.. Glyburide is associated with attenuated vasogenic edema in stroke patients. Neurocritical care 20, 193\u2013201, doi: 10.1007/s12028-013-9917-z (2014).", "ArticleIdList": ["10.1007/s12028-013-9917-z", "PMC5198519", "24072459"]}, {"Citation": "Andrew P. J. & Mayer B. Enzymatic function of nitric oxide synthases. Cardiovascular research 43, 521\u2013531, doi: Doi 10.1016/S0008-6363(99)00115-7 (1999).", "ArticleIdList": ["10.1016/S0008-6363(99)00115-7", "10690324"]}, {"Citation": "Forstermann U. & Sessa W. C. Nitric oxide synthases: regulation and function. European heart journal 33, 829-+, doi: 10.1093/eurheartj/ehr304 (2012).", "ArticleIdList": ["10.1093/eurheartj/ehr304", "PMC3345541", "21890489"]}, {"Citation": "Aarts M. et al.. Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. Science 298, 846\u2013850, doi: 10.1126/science.1072873 (2002).", "ArticleIdList": ["10.1126/science.1072873", "12399596"]}, {"Citation": "Gebska M. A. et al.. PDE5A reciprocally regulates NOS3 expression and activity in vascular endothelial cells. Circulation 114, 283\u2013283 (2006)."}, {"Citation": "Chen Y. C. Beware of docking! Trends Pharmacol Sci 36, 78\u201395, doi: 10.1016/j.tips.2014.12.001 (2015).", "ArticleIdList": ["10.1016/j.tips.2014.12.001", "25543280"]}, {"Citation": "Radi Z. A. & Khan N. K. Expression of COX-1, COX-2, iNOS and p38 in human brain with stroke lesions. Int J Pharmacol 4, 108\u2013113 (2008)."}, {"Citation": "Huang Y. et al.. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study. The Lancet. Neurology 7, 494\u2013499, doi: 10.1016/S1474-4422(08)70094-2 (2008).", "ArticleIdList": ["10.1016/S1474-4422(08)70094-2", "18456558"]}, {"Citation": "Menniti F. S. et al.. Phosphodiesterase 5A inhibitors improve functional recovery after stroke in rats: optimized dosing regimen with implications for mechanism. The Journal of pharmacology and experimental therapeutics 331, 842\u2013850, doi: 10.1124/jpet.109.156919 (2009).", "ArticleIdList": ["10.1124/jpet.109.156919", "19729580"]}, {"Citation": "Hong L. Z., Zhao X. Y. & Zhang H. L. p53-mediated neuronal cell death in ischemic brain injury. Neuroscience bulletin 26, 232\u2013240, doi: 10.1007/s12264-010-1111-0 (2010).", "ArticleIdList": ["10.1007/s12264-010-1111-0", "PMC5560294", "20502500"]}, {"Citation": "Davis A. S., Zhao H., Sun G. H., Sapolsky R. M. & Steinberg G. K. Gene therapy using SOD1 protects striatal neurons from experimental stroke. Neuroscience letters 411, 32\u201336, doi: 10.1016/j.neulet.2006.08.089 (2007).", "ArticleIdList": ["10.1016/j.neulet.2006.08.089", "PMC1716259", "17110031"]}, {"Citation": "Coucha M. et al.. SOD1 overexpression prevents acute hyperglycemia-induced cerebral myogenic dysfunction: relevance to contralateral hemisphere and stroke outcomes. American journal of physiology. Heart and circulatory physiology 308, H456\u2013466, doi: 10.1152/ajpheart.00321.2014 (2015).", "ArticleIdList": ["10.1152/ajpheart.00321.2014", "PMC4346767", "25552308"]}, {"Citation": "Xi G., Reiser G. & Keep R. F. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? Journal of neurochemistry 84, 3\u20139 (2003).", "ArticleIdList": ["12485396"]}, {"Citation": "Thevenet J., Angelillo-Scherrer A., Price M. & Hirt L. Coagulation factor Xa activates thrombin in ischemic neural tissue. Journal of neurochemistry 111, 828\u2013836, doi: 10.1111/j.1471-4159.2009.06369.x (2009).", "ArticleIdList": ["10.1111/j.1471-4159.2009.06369.x", "19719823"]}, {"Citation": "Endres M. et al.. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proceedings of the National Academy of Sciences of the United States of America 95, 8880\u20138885 (1998).", "ArticleIdList": ["PMC21171", "9671773"]}, {"Citation": "Moroni F. Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage. Current opinion in pharmacology 8, 96\u2013103, doi: 10.1016/j.coph.2007.10.005 (2008).", "ArticleIdList": ["10.1016/j.coph.2007.10.005", "18032109"]}]}], "History": [{"Year": "2016", "Month": "8", "Day": "26"}, {"Year": "2016", "Month": "12", "Day": "19"}, {"Year": "2017", "Month": "1", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["28117389", "PMC5259785", "10.1038/srep41406", "srep41406"]}}]}